Investigators found that sphingosine kinase 1 (SPHK1), ceramide galactosyltransferase (UGT8), and ganglioside GD3-synthase (ST8SIA1) showed high expression activity in estrogen receptor-negative BC. This evidence concerns the gene SPHK1 and breast cancer.